Matthew R Patterson's Net Worth

$23.8 Million

Estimate Recalculated Nov 11, 2024 01:51PM EST

Who is Matthew R Patterson

Matthew R Patterson has an estimated net worth of $23.8 Million. This is based on reported shares across multiple companies, which include Vor Biopharma Inc., AMICUS THERAPEUTICS INC, 5:01 Acquisition Corp., Homology Medicines, Inc., and Audentes Therapeutics, Inc..

SEC CIK

Matthew R Patterson's CIK is 0001401018

Past Insider Trading and Trends

2018 was Matthew R Patterson's most active year for acquiring shares with 15 total transactions. Matthew R Patterson's most active month to acquire stocks was the month of January. 2008 was Matthew R Patterson's most active year for disposing of shares, totalling 100 transactions. Matthew R Patterson's most active month to dispose stocks was the month of May. 2019 saw Matthew R Patterson paying a total of $349,067.00 for 312,156 shares, this is the most they've acquired in one year. In 2020 Matthew R Patterson cashed out on 1,158,349 shares for a total of $15,687,480.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Vor Biopharma Inc.

Investor
Updated May 28, 2024
Form 4
30.00K
May 28, 2024
30.00K
Grant
May 23
Form 4
30.00K
Jun 02, 2023
30.00K
Grant
May 26
Form 4
16.91K
Jun 16, 2022
16.91K
Grant
Jun 14
Form 4
16.90K
Feb 09, 2021
16.90K
Grant
Feb 05
Form 3
Feb 04, 2021
41.20K
Showing 5 results

AMICUS THERAPEUTICS INC

Acting CEO & President
Updated Apr 19, 2011
Form 4
88.42%
50.00K
Apr 19, 2011
106.55K
Grant
Apr 18
Form 4
50.00K
Jan 20, 2011
50.00K
Grant
Jan 19
Form 4
30.00K
Jun 17, 2010
30.00K
Grant
Jun 15
Form 4
80.00K
Nov 17, 2009
80.00K
Grant
Nov 16
Form 4
54.00K
Feb 05, 2009
54.00K
Grant
Feb 03
Form 4
$0.64
$12.82K
Dec 04, 2008
56.55K
Options
Dec 02
Form 4
-5.94%
-2.30K
$10.00
-$23.00K
Nov 03, 2008
36.45K
Sale
ScheduledOct 30 - Oct 31
Form 4
-7.63%
-3.20K
$10.39
-$33.26K
Oct 24, 2008
38.75K
Sale
ScheduledOct 22 - Oct 23
Form 4
-9.69%
-4.50K
$10.62
-$47.81K
Oct 22, 2008
41.95K
Sale
ScheduledOct 20 - Oct 21
Form 4
-4.13%
-2.00K
$13.54
-$27.07K
Aug 21, 2008
46.45K
Sale
ScheduledAug 20
Form 4
-14.17%
-8.00K
$14.45
-$115.63K
Aug 20, 2008
48.45K
Sale
ScheduledAug 18 - Aug 19
Form 4/A
-3.18%
-1.90K
$11.01
-$20.91K
Jul 22, 2008
57.85K
Sale
ScheduledJun 18 - Jun 19
Form 4/A
-1.04%
-600.00
$11.44
-$6.73K
Jul 22, 2008
56.45K
Sale
ScheduledJun 20
Form 4
-2.34%
-1.40K
$11.40
-$15.96K
Jun 24, 2008
58.55K
Sale
ScheduledJun 20
Form 4
-3.07%
-1.90K
$11.01
-$20.91K
Jun 20, 2008
59.95K
Sale
ScheduledJun 18 - Jun 19
Form 4
-10.08%
-6.70K
$11.16
-$74.75K
Jun 18, 2008
59.75K
Sale
ScheduledJun 16 - Jun 17
Form 4
-6.34%
-4.50K
$10.18
-$45.80K
Apr 16, 2008
66.45K
Sale
ScheduledApr 14 - Apr 16
Form 4
-7.19%
-5.50K
$10.48
-$57.63K
Apr 16, 2008
70.95K
Sale
ScheduledApr 14
Form 4
$0.64
$7.71K
Feb 25, 2008
96.55K
Options
Feb 21
Form 4
45.00K
Feb 07, 2008
45.00K
Grant
Feb 05
Form 4
$0.64
Aug 28, 2007
96.55K
Options
Aug 15
Form 3
May 30, 2007
32.00K
Showing 22 results

5:01 Acquisition Corp.

Investor
Updated Oct 20, 2020
Form 4
30.00K
Oct 20, 2020
30.00K
Acq/Dis
Oct 16
Form 3
Oct 13, 2020
Showing 2 results

Homology Medicines, Inc.

Investor
Updated Jun 15, 2023
Form 4
23.00K
Jun 15, 2023
23.00K
Grant
Jun 14
Form 4
18.00K
Jun 17, 2022
18.00K
Grant
Jun 15
Form 4
18.00K
Jun 22, 2021
18.00K
Grant
Jun 17
Form 4
18.00K
Jun 12, 2020
18.00K
Grant
Jun 10
Form 4
15.58K
Jun 10, 2019
15.58K
Grant
Jun 06
Form 4
8.36K
Mar 29, 2018
8.36K
Grant
Mar 27
Form 3
Mar 27, 2018
Showing 7 results

Audentes Therapeutics, Inc.

Chief Executive Officer
Updated Jan 15, 2020
Form 4
-100.00%
-1.17M
$60.00
-$26.00M
Jan 15, 2020
Disposition
Jan 15
Form 4
-2.06%
-12.50K
$3.10
$503.57K
Jan 10, 2020
765.18K
Options
Dec 26 - Jan 08
Form 4
-1.74%
-1.97K
$59.21
-$116.88K
Dec 09, 2019
283.23K
Tax
Dec 05
Form 4
-5.09%
-14.43K
$19.75
-$295.73K
Nov 12, 2019
440.60K
Sale
ScheduledNov 08
Form 4
-1.71%
-1.97K
$31.02
-$61.23K
Sep 09, 2019
285.21K
Tax
Sep 05
Form 4
-6.55%
-20.00K
$21.77
-$490.83K
Aug 14, 2019
457.00K
Sale
ScheduledAug 12
Form 4
-2.81%
-3.33K
$37.31
-$124.32K
Jun 07, 2019
287.18K
Tax
Jun 05
Form 4
-7.53%
-21.00K
$15.53
-$607.98K
Feb 27, 2019
429.56K
Sale
ScheduledFeb 25
Form 4
438.45%
241.15K
Feb 08, 2019
467.96K
Grant
Feb 06
Form 4
$0.78
$31.20K
Dec 10, 2018
258.52K
Options
Dec 06
Form 4
-19.50%
-21.00K
$19.47
-$784.99K
Oct 02, 2018
258.52K
Sale
ScheduledOct 01
Form 4
$0.78
$11.70K
Sep 24, 2018
279.52K
Options
Sep 24
Form 4
-9.17%
-12.95K
$21.10
-$489.72K
Sep 20, 2018
300.16K
Sale
ScheduledSep 18
Form 4
-39.75%
-71.05K
$20.17
-$2.75M
Jul 05, 2018
279.52K
Sale
ScheduledJul 02 - Jul 05
Form 4
-10.20%
-20.30K
$19.47
-$758.66K
May 23, 2018
350.56K
Sale
ScheduledMay 21
Form 4
-0.35%
-700.00
$15.40
-$20.46K
Apr 04, 2018
370.86K
Sale
ScheduledApr 02
Form 4
225.00K
Nov 17, 2017
225.00K
Grant
Nov 16
Form 4
-6.30%
-25.00K
$14.35
-$690.27K
Oct 04, 2017
371.56K
Sale
ScheduledOct 02
Form 4
-4.55%
-10.00K
$12.92
-$242.76K
Sep 19, 2017
396.56K
Sale
ScheduledSep 15 - Sep 18
Form 4
-7.43%
-15.00K
$20.00
-$300.06K
Jul 14, 2017
186.81K
Sale
ScheduledJul 12 - Jul 13
Form 4
200.00K
Jan 27, 2017
200.00K
Grant
Jan 25
Form 3
Jul 19, 2016
201.81K
Showing 22 results